SCHEMBL2995893

SCHEMBL2995893

Cc1ccc(C)n1-c1ccc(-c2ccc(C(C)(c3ccc(O)cc3)C(C)C)cc2)nn1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.38
HSP90AA1 P07900 1/20 0.36
HSP90AB1 P08238 1/20 0.36
HPGD P15428 2/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
POLB P06746 1/20 0.30
NFKB1 P19838 1/20 0.30
RAB9A P51151 1/20 0.30
GFER P55789 1/20 0.30
NFKB2 Q00653 1/20 0.30
RELA Q04206 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
RCE1 Q9Y256 1/20 0.30
LMNA P02545 1/20 0.30
TYR P14679 1/20 0.30
ESR1 P03372 1/20 0.30
CYP3A4 P08684 1/20 0.30
AR P10275 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2991950 0.90 ALOX5AP (0.42) ALOX5APSLC6A3
SCHEMBL13262159 0.88 ALOX5AP (0.49) ALOX5APLMNA
SCHEMBL13262240 0.80 ALOX5AP (0.48) ALOX5APLMNA
SCHEMBL2993357 0.78 ALOX5AP (0.60) ALOX5APKDM4ENPC1ALDH1A1RAB9A
SCHEMBL10197152 0.75 ALOX5AP (0.46) ALOX5APHPGDKDM4ENPC1ALDH1A1
SCHEMBL10198931 0.72 ALOX5AP (0.43) ALOX5APRAB9ALMNA
SCHEMBL977392 0.72 ESR1 (0.49) NPC1ALDH1A1POLBRAB9AESR1
SCHEMBL278255 0.71 ESR1 (0.56) HPGDKDM4ENPC1ALDH1A1NFKB1
SCHEMBL978617 0.68 HSD11B1 (0.37) NPC1POLBRAB9ASMN1; SMN2LMNA
SCHEMBL13268158 0.68 CYP3A4 (0.51) ALOX5APHPGDNPC1ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2546232-A1 Diphenyl Substituted Alkanes Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
EP-2546232-A1 Diphenyl Substituted Alkanes Merck Sharp & Dohme Corp. (US) 2013-01-16 EP disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES MERCK SHARP & DOHME CORP. 2010-07-29 US disclosed
WO-2008156721-A1 DIPHENYL SUBSTITUTED ALKANES MERCK & CO., INC. (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190761-A1 DIPHENYL SUBSTITUTED ALKANES ALOX5, ALOX15, ALOX15B ALOX5AP 15/4885HSP90AA1 2403/4885HSP90AB1 2568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.